Physician

Hanni Salih, M.D.

According to 2025 Medicare claims, Hanni Salih, M.D. (NPI: 1245594639) practices hematology/oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (NPI: 1770664542; TIN: 742915297) and primary practice location at 78229-3307.

Salih's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 111,728 HCPCS/CPT codes, and received $2,562,595 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,227 prescription claims across 259 beneficiaries totaling $3,975,315 in drug costs, led by Sprycel (Dasatinib). Open Payments data shows 47 records totaling $1,183. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $58,034 to $2,562,595. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,810 to $3,975,315. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	65	3,916	$58,034
2019	387	64,955	$485,076
2020	252	47,627	$675,073
2021	286	67,615	$890,911
2022	278	77,280	$1,069,645
2023	335	101,834	$1,757,028
2024	356	111,728	$2,562,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	105	$6,810
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	12	26	$48,117
2019	76	267	$288,373
2020	84	476	$741,812
2021	101	618	$1,106,352
2022	191	973	$1,648,996
2023	220	1,096	$2,175,784
2024	259	1,227	$3,975,315

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	269	548	$90
80053	Blood test, comprehensive group of blood chemicals	226	664	$10
36415	Insertion of needle into vein for collection of blood sample	242	715	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	210	653	$8
83615	Lactate dehydrogenase (enzyme) level	140	258	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sprycel	Dasatinib	37	1,110	$570,139
Cabometyx	Cabozantinib S-Malate	20	590	$434,334
Lenalidomide	Lenalidomide	23	644	$420,605
Erleada	Apalutamide	16	480	$239,094
Erivedge	Vismodegib	17	490	$229,427

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$1,183	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hanni Salih, M.D.?

Tedicare shows public-source Medicare data for Hanni Salih, M.D. (NPI 1245594639), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hanni Salih, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hanni Salih, M.D.?

Hanni Salih, M.D. is linked to SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC (billing NPI 1770664542) in the available physician profile data.

Does Hanni Salih, M.D. have Open Payments data?

Hanni Salih, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.